These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

314 related articles for article (PubMed ID: 33787963)

  • 1. Efficacy of ketamine for major depressive episodes at 2, 4, and 6-weeks post-treatment: A meta-analysis.
    Conley AA; Norwood AEQ; Hatvany TC; Griffith JD; Barber KE
    Psychopharmacology (Berl); 2021 Jul; 238(7):1737-1752. PubMed ID: 33787963
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A systematic review and meta-analysis of randomized, double-blind, placebo-controlled trials of ketamine in the rapid treatment of major depressive episodes.
    McGirr A; Berlim MT; Bond DJ; Fleck MP; Yatham LN; Lam RW
    Psychol Med; 2015 Mar; 45(4):693-704. PubMed ID: 25010396
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Baseline delta sleep ratio predicts acute ketamine mood response in major depressive disorder.
    Duncan WC; Selter J; Brutsche N; Sarasso S; Zarate CA
    J Affect Disord; 2013 Feb; 145(1):115-9. PubMed ID: 22871531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ketamine as a novel treatment for major depressive disorder and bipolar depression: a systematic review and quantitative meta-analysis.
    Lee EE; Della Selva MP; Liu A; Himelhoch S
    Gen Hosp Psychiatry; 2015; 37(2):178-84. PubMed ID: 25698228
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rapid relief of severe major depressive disorder by use of preoperative ketamine and electroconvulsive therapy.
    Goforth HW; Holsinger T
    J ECT; 2007 Mar; 23(1):23-5. PubMed ID: 17435569
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Ketamine in acute and severe major depressive disorder].
    Brittner M; Micoulaud-Franchi JA; Richieri R; Boyer L; Adida M; Lancon C; Fond G
    Presse Med; 2014 May; 43(5):492-500. PubMed ID: 24630265
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors of Response to Ketamine in Treatment Resistant Major Depressive Disorder and Bipolar Disorder.
    Rong C; Park C; Rosenblat JD; Subramaniapillai M; Zuckerman H; Fus D; Lee YL; Pan Z; Brietzke E; Mansur RB; Cha DS; Lui LMW; McIntyre RS
    Int J Environ Res Public Health; 2018 Apr; 15(4):. PubMed ID: 29673146
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of ketamine as an antidepressant: a systematic review and meta-analysis.
    Coyle CM; Laws KR
    Hum Psychopharmacol; 2015 May; 30(3):152-63. PubMed ID: 25847818
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rapid antidepressant effects of repeated doses of ketamine compared with electroconvulsive therapy in hospitalized patients with major depressive disorder.
    Ghasemi M; Kazemi MH; Yoosefi A; Ghasemi A; Paragomi P; Amini H; Afzali MH
    Psychiatry Res; 2014 Feb; 215(2):355-61. PubMed ID: 24374115
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ketamine and Other NMDA Antagonists: Early Clinical Trials and Possible Mechanisms in Depression.
    Newport DJ; Carpenter LL; McDonald WM; Potash JB; Tohen M; Nemeroff CB;
    Am J Psychiatry; 2015 Oct; 172(10):950-66. PubMed ID: 26423481
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Single and repeated ketamine treatment induces perfusion changes in sensory and limbic networks in major depressive disorder.
    Sahib AK; Loureiro JRA; Vasavada MM; Kubicki A; Joshi SH; Wang K; Woods RP; Congdon E; Wang DJJ; Boucher ML; Espinoza R; Narr KL
    Eur Neuropsychopharmacol; 2020 Apr; 33():89-100. PubMed ID: 32061453
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ketamine for Treatment-Resistant Depression: a New Advocate.
    Pérez-Esparza R
    Rev Invest Clin; 2018; 70(2):65-7. PubMed ID: 29718013
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Ketamine followed by memantine for the treatment of major depression.
    Kollmar R; Markovic K; Thürauf N; Schmitt H; Kornhuber J
    Aust N Z J Psychiatry; 2008 Feb; 42(2):170. PubMed ID: 18197514
    [No Abstract]   [Full Text] [Related]  

  • 14. A randomized, crossover comparison of ketamine and electroconvulsive therapy for treatment of major depressive episodes: a Canadian biomarker integration network in depression (CAN-BIND) study protocol.
    Phillips JL; Jaworska N; Kamler E; Bhat V; Blier J; Foster JA; Hassel S; Ho K; McMurray L; Milev R; Moazamigoudarzi Z; Placenza FM; Richard-Devantoy S; Rotzinger S; Turecki G; Vazquez GH; Kennedy SH; Blier P;
    BMC Psychiatry; 2020 Jun; 20(1):268. PubMed ID: 32487236
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Glutamatergic approaches in major depressive disorder: focus on ketamine, memantine and riluzole.
    Owen RT
    Drugs Today (Barc); 2012 Jul; 48(7):469-78. PubMed ID: 22844658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Regulation of neural responses to emotion perception by ketamine in individuals with treatment-resistant major depressive disorder.
    Murrough JW; Collins KA; Fields J; DeWilde KE; Phillips ML; Mathew SJ; Wong E; Tang CY; Charney DS; Iosifescu DV
    Transl Psychiatry; 2015 Feb; 5(2):e509. PubMed ID: 25689570
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effectiveness of ketamine on anxiety, irritability, and agitation: Implications for treating mixed features in adults with major depressive or bipolar disorder.
    McIntyre RS; Lipsitz O; Rodrigues NB; Lee Y; Cha DS; Vinberg M; Lin K; Malhi GS; Subramaniapillai M; Kratiuk K; Fagiolini A; Gill H; Nasri F; Mansur RB; Suppes T; Ho R; Rosenblat JD
    Bipolar Disord; 2020 Dec; 22(8):831-840. PubMed ID: 32406161
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The novel antidepressant ketamine enhances dentate gyrus proliferation with no effects on synaptic plasticity or hippocampal function in depressive-like rats.
    Michaëlsson H; Andersson M; Svensson J; Karlsson L; Ehn J; Culley G; Engström A; Bergström N; Savvidi P; Kuhn HG; Hanse E; Seth H
    Acta Physiol (Oxf); 2019 Apr; 225(4):e13211. PubMed ID: 30347138
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Comparing the actions of lanicemine and ketamine in depression: key role of the anterior cingulate.
    Downey D; Dutta A; McKie S; Dawson GR; Dourish CT; Craig K; Smith MA; McCarthy DJ; Harmer CJ; Goodwin GM; Williams S; Deakin JF
    Eur Neuropsychopharmacol; 2016 Jun; 26(6):994-1003. PubMed ID: 27133029
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Anhedonia as a clinical correlate of suicidal thoughts in clinical ketamine trials.
    Ballard ED; Wills K; Lally N; Richards EM; Luckenbaugh DA; Walls T; Ameli R; Niciu MJ; Brutsche NE; Park L; Zarate CA
    J Affect Disord; 2017 Aug; 218():195-200. PubMed ID: 28477497
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.